Skip to main content

MDVN News

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Geron Spikes on New Data

OncoMed Pharmaceuticals, Geron and Akorn were among the biotech stock movers in premarket trading on Monday.

Medivation Founder Takes Helm at Axovant, Shares Spike

David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.

Clovis, Tesaro soar on AstraZeneca phase three news

AstraZeneca shares, meanwhile, were less-than-moved by the news.

Biotech Tesaro climbs on takeout reports

The company's shares were up 14% on rumors that it is working with investment banks to consider a sale.

2016 was a terrible year for biotech but the tweets were on point

A look back at the year's worth of Adam Feuerstein's biotech tweets.

Breaking News

Bally's Close to Making a Huge Las Vegas Strip Deal

The casino operator does not own the casino that carries its name, but changes are in the works.

There's a Big Shift Coming for Airline Passengers

People who are traveling by air are about to see a change in recent trends.

New Coca-Cola Flavor is So Hip, It Comes With Its Own QR Code

Beverage giant is rolling out a new taste in its efforts to attract and keep a key demographic.

You'll Almost Have to Buy an Electric Vehicle if Climate Bill Passes

You can find savings on everything from EVs to solar panels in the Inflation Reduction Act.